JNCI Cancer Spectrum

Oxford University Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

JNCI Cancer Spectrum is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 1,951 USD. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
2515-5091
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
1,951 USD
Articles in DOAJ
0
Declared review time
18 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2018-04-23
  • MEDLINE · 2021-01-01
  • PUBMED · 2021-01-05
Indexing
DOAJ · MEDLINE · PUBMED
APC
1,951 USD
Declared review time (DOAJ)
18 weeks
Actual review time (measured)
125 days received→accepted — computed from PubMed (n=97)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

18weeks

Works in OpenAlex

948

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

54

i10-index

397

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-03
Added to DOAJ
2018-04-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
94%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Journal of the National Cancer Institute cancer spectrumJNCI CS
Source type
journal
NLM unique ID (PubMed)
101721827
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensMedicine: Public aspects of medicine

LCC codes

RC254-282RA1-1270

Subject areas

  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
Show all subjects (50)
  • Childhood Cancer Survivors' Quality of Life
  • Childhood Cancer Survivors' Quality of Life
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Screening and Detection
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Screening and Detection
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Cancer-related cognitive impairment studies
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer-related cognitive impairment studies
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Nutrition and Health in Aging
  • Nutrition and Health in Aging
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Cervical Cancer and HPV Research
  • Cervical Cancer and HPV Research
  • Metabolism, Diabetes, and Cancer
  • COVID-19 and healthcare impacts
  • COVID-19 and healthcare impacts
  • Metabolism, Diabetes, and Cancer
  • Ethics in Clinical Research
  • Ethics in Clinical Research
  • Nutritional Studies and Diet
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Nutritional Studies and Diet

Keywords (DOAJ)

  • oncology
  • cancer screening
  • cancer prevention
  • epidemiology
  • public health

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: